We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Surprise Finding May Lead to Drugs for Treating Ewing Sarcoma

By LabMedica International staff writers
Posted on 04 Dec 2012
Cancer researchers have uncovered a previously unknown molecular function for the EWS/FLI fusion gene that may lead to the development of drugs to treat Ewing sarcoma, an often-fatal cancer of children and young adults.

Genetic exchange between chromosomes can cause cells to become cancerous, and about 85% of Ewing's sarcoma cases are the result of a translocation between chromosomes 11 and 22, which fuses the EWS gene of chromosome 22 to the FLI1 gene of chromosome 11. More...
EWS/FLI then functions as the master regulator for cancer development.

Investigators at the University of Utah (Salt Lake City, USA) studied the interaction of EWS/FLI and the enzyme lysine specific demethylase (LSD-1), a flavin-dependent monoamine oxidase, which can demethylate mono- and di-methylated lysines, specifically histone three, lysines four and nine (H3K4 and H3K9).

The investigators reported in the November 26, 2012, online edition of the journal Oncogene that the EWS/FLI/LSD-1 combination blocked certain gene activities, which prompted development and spread of Ewing sarcoma cells. This finding complemented earlier results that showed that binding to DNA by the protein encoded by EWS/FLI led to development of Ewing sarcoma.

Recently discovered LSD-1 inhibitors were found to block growth of Ewing sarcoma cells in culture, and studies are to be extended to animal models.

"This makes LSD-1 an important target for the development of new drugs to treat Ewing sarcoma," said senior author Dr. Stephen Lessnick, professor of pediatrics at the University of Utah. "We think it may play a larger role in Ewing sarcoma than simply turning off a handful of genes, and we are looking into that."

"For a long time, we have known that EWS/FLI works by binding to DNA and turning on genes that activate cancer formation," said Dr. Lessnick. "It was a surprise to find out that it turns genes off as well. The beauty, if there is anything beautiful about a nasty disease like this, is that if we can inhibit EWS/FLI, we can inhibit this cancer, because EWS/FLI is the master regulator of Ewing sarcoma."

Related Links:

University of Utah




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Portable POCT Blood Gas Analyzer
BD100
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.